Skip to main content

Table 2 Relationship between RPL35A expression and tumor characteristics in patients with gastric cancer

From: RPL35A is a key promotor involved in the development and progression of gastric cancer

Features No. of patients RPL35A expression P value
Low High
All patients 110 65 45  
Age (years)     0.070
 < 64 53 36 17  
 ≥ 64 57 29 28  
Gender     0.869
 Male 84 50 34  
 Female 26 15 11  
T Infiltrate     0.042
 T1 5 4 1  
 T2 17 11 6  
 T3 65 41 24  
 T4 23 9 14  
Lymphatic metastasis (N)     0.754
 N0 20 13 7  
 N1 18 12 6  
 N2 26 12 14  
 N3 46 28 18  
Stage     0.631
 I 9 5 4  
 II 32 21 11  
 III 68 38 30  
 IV 1 1 0  
Tumor size     0.591
 < 5 cm 46 26 20  
 ≥ 5 cm 55 34 21  
Vessel carcinoma embolus     0.539
 0 26 14 12  
 1 54 33 21  
Nerve tumor infiltrates     0.425
 0 36 22 14  
 1 20 10 10  
Expession of Ki67     0.404
 < 60% 47 25 22  
 ≥ 60% 52 32 20  
Expession of CD34     0.346
 No 15 6 9  
 Yes 29 16 13  
Expession of EGFR     0.531
 No 85 47 38  
 Yes 14 9 5  
Expession of VEGF     0.343
 No 34 17 17  
 Yes 65 39 26  
Expession of CDX2     0.892
 No 18 10 8  
 Yes 82 47 35  
Expession of Her2     0.948
 No 72 41 31  
 Yes 26 15 11